DATE/TIME
September 26, 11:20 – 12:00 PM EST
TITLE
The Future of Pharma Operations & Quality
SPEAKERS
Mayank Nagar
Vice President & Head of Technical Services and New Product Launches, North America
Dr. Reddy’s Laboratories
ABSTRACT
Pharma business is facing a multitude of forces that will test the pharmaceutical industry’s resilience in the years ahead. These challenges range from those that have been conventional to the Pharma environment, to the recent vulnerabilities that have surfaced during the Covid-19 pandemic and the recovery period. Succeeding in pharma under these new and challenging conditions will require succeeding in operations and leveraging quality to win.
The discussion will examine key themes shaping pharma’s outlook, as well as the strategies companies will deploy to stay in front of these rapidly changing dynamics. The talk will also uncover the challenges being faced, and the steps industry can take to develop a more strategic, long-term, and integrated approach to operations and quality.
BIO
Mayank Nagar is a Pharma professional with over 25 years of global leadership experience in pharma operations, consulting, compliance and quality management systems. He has been employed with pharma corporates and advisory companies and provided services and solutions to a broad range of companies/clients including innovators, generic manufacturers, biopharmaceutical companies, startups, and global health organizations. His contributions include enabling new product launches, analyzing technical and business risks, developing operational strategies, and helping to overcome regulatory crisis to achieve business targets.
Mayank is an accomplished professional in liaison and analytical skills with the ability to work in a multi-cultural environment. He has successfully handled several cross cultural/international responsibilities at various locations in India, the U.S., Ireland, Romania, Brazil, South Africa and Malaysia.
Mayank brings a unique combination of technical expertise and business acumen to his role. He is well versed with global quality regulations and successfully guided teams for several U.S. FDA and EU inspections. He has handled a diverse range of pharmaceutical dosage forms including drug-device combination products, sterile liquids and dry powders, complex solid dosage forms, liquid preparations and semisolids, sublingual films, patches, and inhalations. He has expertise in business due diligence, having conducted audits to support several mergers and acquisitions.
